Clarivate™ is a global leader in providing trusted information and insights to accelerate the pace of innovation. The firm offers subscription and technology-based solutions coupled with deep domain expertise that cover the entire lifecycle of innovation – from foundational research and ideas to protection and commercialization. Today, the company is setting a trail-blazing course to help customers turn bold ideas into life-changing inventions. Its portfolio consists of some of the world’s most trusted information brands, including the Web of Science™, Cortellis™, Derwent™, CompuMark™, MarkMonitor™ and Techstreet™.
29 Reviews
Diverse but that is due to acquisitions. Global coworkers. Good industry knowledge esp if you are PM as it serves BioPharma. Will be mostly remote. Money makers as the never loose money. Yearly RSUs if company meets an NPS score.
Upper management has SPAC mentality. All new hiring needs to be in India or Spain. They save money by not hiring in costly countries and instead acquire companies. Most departments have poor leaders and no proper career growth guidance. Big time attrition and revolving door. Many offices closed world wide.
Two ILS scientists, Drs. Sanjeeb Sahoo, Amaresh C. Panda, and Pulok Kumar Mukherjee, Director, ILS (Additional Charge), are among the World’s Most Influential Scientific Minds’ in 2022.
Clarivate’s shares have fallen 70% in as its debt load has increased after a spate of large acquisitions. See why we’d stay on the sidelines on CLVT stock.